Intended Use Advantage Typhi IgM & IgG Card is a rapid solid phase immuno-chromatographic test for the qualitative differential and simultaneous detection of salmonella typhi (S. typhi) IgM and IgG antibodies in human serum / plasma. This test is for in vitro diagnostic use only and is intended as an aid in the earlier diagnosis of typhoid infection and in the determination of recent and past infection. Salient Features Rapid qualitative test for differential detection of Salmonella typhi (S.typhi) IgM and IgG Antibodies in Human Serum / Plasma Determination of both recent and past infection Results within 20 minutes Bio-hazard free, fully covered, see-through Device Simple & Easy to use Test Procedure No Instruments required Long Shelf Life: 30 months at 2-30ºC Convenient Pack size: 50 Tests

STANDARD Q TB MPT64 Ag STANDARD Q TB MPT64 Ag performs qualitative analysis by detecting Mycobacterium tuberculosis (TB) MPT64 antigen in solid culture or liquid culture samples using immunochromatography. With a simple test method, the screening test result can be obtained within 10 minutes with its high sensitivity and specificity.

Product discrition:- Simple, Fast, Accurate Suitable for the clinical laboratories No need thermal chamber 12 tests available at once High throughput results – up to 120 tests in an hour Compact desktop instrument No consumables 7’’ touch screen LCD Save ID chip information to analyzer

n large laboratories, rows of instruments are seen working tirelessly like miniature factories – only they produce not commodities but medical test results. Mindray CAL 8000 new-generation cellular automation line is one of them, but unlike a typical workhorse, it is intelligent. It is a highly automated workstation for smarter, faster, and more accurate cellular analysis. It can perform competently in the face of these challenges. The workstation can hold up to four units of BC-6800 automated hematology analyzer, which utilizes the advanced SF Cube technology and 3-D scatter grams to help doctors better differentiate blood cell populations and reveal abnormal cells undetectable by conventional techniques. With 125 CBC tests per hour per unit, BC-6800 brings the process rate of the workstation to 20–30 percent higher than other similar models, effectively alleviating laboratory's stress during the peak processing hours. On CAL 8000, the hematology analyzer, slide maker and stainer, CRP analyzer, and HbA1c analyzer are all integrated into one seamless production line through automated track modules and trolley. Simply by loading a single tube of blood sample onto the automation system, one can get all the test results. This innovative walk-away automation functionality has made possible the CBC+CRP+HbA1c testing all in one streamlined workstation for the first time in the industry. It offers a smart solution, or rather, a smart expert – the labX pert 2.0. It is a software that can automatically sort out the suspected samples for manual validation. The pathologist then decides if rerun or microscopic review is warranted based on their clinical experience. It avoids wasting slides and reduces extra work. Moreover, the onboard automated re-exam functionality also helps enhance work efficiency. The CMU software The touch screen is the “brain” of CAL 8000. It optimizes the distribution of workload between each analyzer unit and decides which sample requires a blood smear. It displays the status of each analyzer or SC-120 installed on CAL 8000 as well as the volume of balance reagent. This intuitive software can tell the users all necessary information of CAL 8000 at any given time. Consequently, the users spend less time operating CAL 8000 and can arrange their working schedule better. Multi “R” tests The CAL 8000 can automatically distribute the samples with “Repeat”, “Rerun” and “Reflex” criteria which are pre-defined by users.The re-exam criteria on CAL 8000 can be defined by many conditions, such as time, patient’s age, gender, department, etc. This helps minimize the number of blood smears. Special tube racks The special tube racks utilize different barcodes to differentiate specific testing purposes, such as “QC”, “Slide making & staining only” and “RET test only”. The special tube racks can carry the tubes to perform these specific functions in the simplest way.

Since the company was founded, Mindray has been continuously exploring new ways to improve diagnostic confidence. Powered by the most revolutionary ZONE Sonography® Technology, Resona 7’s new ZST+ platform brings ultrasound image quality to a higher level by zone acquisition and channel data processing. As well as the premium level image quality, Resona 7 also enhances clinical research capabilities with the revolutionary V Flow for vascular hemodynamic evaluation, and the most intelligent plane acquisition from 3D datasets for fetal CNS diagnosis. Combining the most intuitive gesture-based multi-touch operation and all the essential clinical features, Resona 7 is truly leading new waves in ultrasound innovation. With core platform advantages of ZST+ The channel data based ZST+ is an extraordinary innovation, representing an ultrasound evolution. Transforming ultrasound metrics from conventional beamforming to channel data based processing, ZST+ is able to deliver multiple imaging advances: Advanced Acoustic Acquisition, Dynamic Pixel Focusing, Sound Speed Compensation, Enhanced Channel Data Processing and Total Recall Imaging. Advanced features V Flow V Flow (Vector Flow) is a novel approach for vascular hemodynamic analysis. V Flow uses color coded vector arrows to indicate the velocity’s magnitude and direction of blood cells. With ultra-high frame rates, it provides extremely accurate and angle-independent visualization of complex vascular hemodynamic profiles. With comprehensive data information, V Flow is the most valuable tool for vascular clinical research. resona-7-fig3-1-pc UWN+ Contrast Imaging UWN+ (Ultra-Wideband Non-linear Plus) CEUS enables the Resona 7 to detect and utilize both the 2nd harmonic and non-linear fundamental signals, generating significantly enhanced images, resulting in greater sensitivity of minor signals and longer agent duration with lower MI. Forwarding smart to clinical intelligence The Resona 7 elevates clinical intelligence with a complete solution that enables clinicians to manage both routine and advanced studies more efficiently,consistently, and accurately, from acquisition to calculation. As an example, Smart Planes CNS shows exceptional intelligence in accurate diagnosis and analysis of the fetal central nervous system (CNS) Smart Planes CNS Mindray’s exclusive pioneering technology positions the Resona 7 as the industry’s first ultrasound system to allow fully automatic and accurate detection of the most significant planes and frequently used measurements of fetal CNS, leading to intelligent diagnosis, improved throughput, and reduced user dependence. Smart Planes CNS provides a user-friendly tool that greatly improves scanning efficiency through increased accuracy coupled with automated operation. With a simple button click on a 3D fetal brain volume image, the standard CNS scanning planes (MSP, TCP, TTP and TVP) and a range of related anatomical measurements (BPD, HC, OFD, TCD, CM and LVW) are obtained immediately. Smart Face Acquiring an optimal view of the fetal face in 3D ultrasound is cumbersome and time-consuming. In some cases, it is impossible to get rid of the occlusions such as cord, placenta, uterus and extremities. The new Resona 7 with Zone Intelligence provides a fast and intelligent optimization for fetal face with simply one-touch. It can immediately remove occlusions in the volume data, eliminate unwanted noise information, and generate an optimal view of the fetal face with minimal effort. Ergonomics The Resona 7 is designed around you. Gesture-based operation opens up a new trend in cart-based ultrasound with an agile, smart, and intuitive user experience beyond your expectations. Gel warmer’s three level temperature and swiveling angle adjustment of the control panel delivers great patient comfort and user convenience.

The OnSite HSV-2 IgG/IgM Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection and differentiation of antibodies (IgG and IgM) to herpes simplex virus 2 (HSV-2) in human serum, plasma or whole blood. Unique test that utilizes glycoprotein G2 to differentiate between HSV-1. and HSV-2 that allows for an early start of treatment action. Immediate determination of either acute or chronic infection by detecting and differentiating IgG and IgM anti-HSV-2. High confidence as test is in agreement with market leading European ELISA: 95.3% IgG; 100% IgM. Flexible specimen types including serum, plasma, or whole blood which allows testing at any time without special specimen preparation. Small sample volume (10 µL) enables multiple testing on the same specimen without having to re-draw the patient. Initial treatment action can begin during patient’s visit as test results are available in 10 minutes. Easily transported, and can be stored for 24 months, 2-30oC. Individually sealed foil pouches containing: One cassette device One desiccant Capillary tubes (10 µL) Sample diluent (REF SB-R0213, 5 mL/bottle) Package insert (instruction for use) CTK Products at a Glance HSV-1 & HSV-2 Flyer Insert U.S. CDC HSV Homepage: Genital Herpes Fact Sheets WHO: Herpes Simplex Virus Fact Sheets

The OnSite HSV-1 IgG/IgM Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection and differentiation of antibodies (IgG and IgM) to herpes simplex virus 1 (HSV-1) in human serum, plasma or whole blood. Type-specific detection by utilizing glycoprotein G1. Single test that detects and differentiates IgG and IgM anti-HSV-1. High confidence as test is in agreement with market leading ELISA test: 90.7% IgG; 85.0% IgM. Flexible specimen types including serum, plasma, or whole blood which allows testing at any time without special specimen preparation. Small sample volume (10 µL) enables multiple testing on the same specimen without having to re-draw the patient. Initial treatment action can begin during the patient’s visit as test results are available in 10 minutes. Easily transported, and can be stored for 24 months, 2-30oC. Individually sealed foil pouches containing: One cassette device One desiccant Capillary tubes (10 µL) Sample diluent (REF SB-R0203, 5 mL/bottle) Package insert (instruction for use) CTK Products at a Glance HSV-1 & HSV-2 Flyer Insert U.S. CDC HSV Homepage: Genital Herpes Fact Sheets WHO: Herpes Simplex Virus Fact Sheets

The OnSite S. Typhi/Paratyphi Ag Rapid Test is a lateral flow chromatographic immunoassay for the simultaneous detection and differentiation of Salmonella typhi (S. typhi) and Salmonella paratyphi (S. paratyphi) antigens in a human fecal specimen and blood culture specimen. Detects the specific antigens from either S. typhi or S. paratyphi Earlier detection results in faster treatment for disease eradication Works with a variety of specimen types including: fecal, blood culture Simple procedure minimizes operator error due to sample preparation Test result within 15 minutes allows medical professionals to take immediate action High level of reproducibility Test kits can be used and stored at room temperature Individually sealed foil pouches containing: One cassette device One desiccant Stool collection devices, each containing 1 mL Fecal Sample Extraction Buffer (REF SB-R0162) Sample diluent (REF SB-R0162-2, 5 mL/bottle) Plastic droppers Patient ID stickers One package insert (instruction for use) CTK Products at a Glance Flyer Inserts U.S. CDC Typhoid Homepage: About Typhoid WHO: Health Topic for Typhoid CATALOG # PRODUCT QUANTITY SPECIMEN R0162C S. Typhi/Paratyphi Ag Rapid Test 25/kit Fecal, Blood Culture OTHER PRODUCTS YOU MIGHT BE INTERESTED IN… CATALOG # PRODUCT QUANTITY SPECIMEN R0161C Typhoid IgG/IgM Combo Rapid Test 30/kit S, P & WB

The OnSite Duo HSV-1/2 IgG/IgM Rapid Test is a lateral flow chromatographic immunoassay for qualitative detection and differentiation of antibodies (IgG and IgM) to herpes simplex virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2) in human serum, plasma or whole blood. This test can be performed in 10 minutes by minimally skilled personnel without the use of laboratory equipment. This test is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with HSV-1 and/or HSV-2. The OnSite Duo HSV-1/2 IgG/IgM Rapid Test uses HSV-1 glycoprotein G1 and HSV-2 glycoprotein G2 for the specific detection and differentiation of IgG and IgM antibodies to HSV-1 and HSV-2 in serum, plasma and whole blood. An HSV-1 and/or HSV-2 IgM positive result indicates an active infection, which may be primary or recurrent. An HSV-1 and/or HSV-2 IgG positive result indicates a recent or past infection. However, a negative test result does not preclude the possibility of infection with HSV-1 and/or HSV-2. Any interpretation or use of this preliminary test result must also rely on other clinical findings as well as on the professional judgment of health care providers. Alternative test method(s) should be considered to confirm the test result obtained by this device. Clinical accuracy: 90.6% sensitivity and 91.4% specificity for anti-HSV-1 IgG detection 93.8% sensitivity and 96.0% specificity for anti-HSV-2 IgG detection 85.0% overall agreement for anti-HSV-1 IgM detection comparing to commercial ELISA 100% overall agreement for anti-HSV-2 IgM detection comparing to BBI Panel (PTH202) Positive rate on random clinical specimens:8% for IgG anti-HSV-1 and 4.9% for IgM anti-HSV-1 (n=10,000); 4.6% for anti-HSV-2 IgG and 1.7% for anti-HSV-2 IgM Cross reactivity: no cross reactivity with the following disease states or special conditions, respectively: palladium, H. pylori, Dengue, Malaria, Typhoid, Toxoplasma, Rubella, CMV, hCG, TB, HAV, HBV, HCV, HEV, HIV, ANA, HAMA, RF (up to 1,000 IU/mL) Interference: No interference was seen with Albumin 60 g/L , Hemoglobin 2 g/L, Bilirubin 20 mg/dL, Heparin 3,000 U/L, Creatinine 442 µmol/L, Salicylic acid 4.24 mmol/L, EDTA 3.4 µmol/L, Sodium citrate 8%, Glucose 55 mmol/L Shelf life: 24 months Individually sealed foil pouches containing: One cassette device One desiccant Capillary tubes (10 µL) Sample diluent (REF SB-R0203, 5 mL/bottle) Package insert (instruction for use) Individually sealed foil pouches containing: One cassette device One desiccant Capillary tubes (10 µL) Sample diluent (REF SB-R0203, 5 mL/bottle) Package insert (instruction for use)